Study of Mechanism of Action of Ligelizumab (QGE031) in Patients With Chronic Urticaria
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Chronic Spontaneous Urticaria
Related studies linked through entity extraction aliases.
A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UCB8600 in Healthy Participants, Atopic Participants, and Chronic Spontaneous Urticaria Participants
- Status
- TERMINATED
- Phase
- PHASE1
Study to Evaluate the Safety, Tolerability and Efficacy of Cannabidiol (CBD) as a Steroid-sparing Therapy in Chronic Spontaneous Urticaria (CSU) Patients
- Status
- COMPLETED
- Phase
- PHASE2
To Compare Efficacy and Safety of CT-P39 and EU-approved Xolair in Patients With Chronic Spontaneous Urticaria
- Status
- COMPLETED
- Phase
- PHASE3
Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of UB-221 in Healthy Volunteers
- Status
- UNKNOWN
- Phase
- PHASE1
Frequency of Parasite Infestation in Patients With Chronic Spontaneous Urticaria
- Status
- COMPLETED
- Phase
- N/A
Study of Efficacy and Safety of Ligelizumab in Chronic Spontaneous Urticaria Patients Who Completed a Previous Study With Ligelizumab
- Status
- TERMINATED
- Phase
- PHASE3
Shotblocker® Use in Subcutaneous Injection
- Status
- COMPLETED
- Phase
- NA
Dupilumab for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine and Who Are naïve to, Intolerant of, or Incomplete Responders to Omalizumab (LIBERTY-CSU CUPID)
- Status
- COMPLETED
- Phase
- PHASE3
A Study of LY3454738 in Adults With Chronic Spontaneous Urticaria
- Status
- TERMINATED
- Phase
- PHASE2
An Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of LOU064 in Subjects With CSU
- Status
- COMPLETED
- Phase
- PHASE2
This Was a Dose-finding Study to Evaluate Efficacy and Safety of LOU064 in Patients With CSU Inadequately Controlled by H1-antihistamines
- Status
- COMPLETED
- Phase
- PHASE2
A Safety and Efficacy Study of Ligelizumab in the Treatment of CSU in Japanese Patients Inadequately Controlled With H1- Antihistamines
- Status
- COMPLETED
- Phase
- PHASE3
Tranexamic Acid and Spontaneous Chronic Urticaria
- Status
- UNKNOWN
- Phase
- PHASE4
Dupilumab in Chronic Spontaneous Urticaria
- Status
- COMPLETED
- Phase
- PHASE2
A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Phase III Study of Safety and Efficacy of Ligelizumab in the Treatment of CSU in Adolescents and Adults Inadequately Controlled With H1-antihistamines
- Status
- COMPLETED
- Phase
- PHASE3
A Phase III Study of and Efficacy of Ligelizumab in the Treatment of CSU in Adolescents and Adults Inadequately Controlled With H1-antihistamines.
- Status
- COMPLETED
- Phase
- PHASE3
Mepolizumab for the Treatment of Chronic Spontaneous Urticaria
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Study to Investigate the Efficacy and Safety of QGE031 in Adolescent Patients With Chronic Spontaneous Urticaria (CSU)
- Status
- COMPLETED
- Phase
- PHASE2